Search


Hopewell Therapeutics’ CEO on the company’s $25M raise and next-gen LNPs
Lou Brenner discusses his company’s raise today and explains how Hopewell is designing LNPs to go beyond the liver.
Jun 7, 2023
Also look for unique social pages for BiotechTV U.
10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.
Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.